Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma [4]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 12, 2007, Pages 1410-1411

  Junna, Mithri R ^a   Rabinstein, Alejandro A ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; FOSPHENYTOIN SODIUM; PROPOFOL; TACROLIMUS;

ANAMNESIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EYE MOVEMENT; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; LEUKOENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

EID: 36849084545     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.121806     Document Type: Letter

References (5)

1. Wijdicks EF. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001;7:937-42.
2. Reinohs M, Straube T, Baum P, et al. Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. J Neurol 2002;249:780-1.
3. Prescott WA Jr, Callahan BL, Park JM. Tacrolimus toxicity associated with concomitant metoclopramide therapy. Pharmacotherapy 2004;24:532-7.
4. Furukawa M, Terae S, Chu BC, et al. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. Neuroradiology 2001;43:615-21.
5. Lavigne CM, Shrier DA, Ketkar M, et al. Tacrolimus leukoencephalopathy: a neuropathologic confirmation. Neurology 2004;63:1132-3.